Would you switch a patient with glucocorticoid induced osteoporosis to romosozumab if a patient sustained a fragility fracture 1 year into treatment with teriparatide?
Answer from: at Academic Institution
This is an interesting question for which there is no evidence-based medicine. It would be important to know what bone was broken. If it was a vertebral fracture I would likely suggest a change to romosozumab because vertebral fractures are usually not traumatic and are the purest osteoporotic fract...
Comments
at Montefiore Medical Center Thank you so much, this is very helpful!
at Director Agree with Dr. @Stephen Honig’s evaluation b...
at Arthritis Clinic of Central Texas Great answer, thank you!
Thank you so much, this is very helpful!
Agree with Dr. @Stephen Honig’s evaluation b...
Great answer, thank you!
Very insightful!